541 related articles for article (PubMed ID: 15728892)
1. Mechanism of action of T-705 against influenza virus.
Furuta Y; Takahashi K; Kuno-Maekawa M; Sangawa H; Uehara S; Kozaki K; Nomura N; Egawa H; Shiraki K
Antimicrob Agents Chemother; 2005 Mar; 49(3):981-6. PubMed ID: 15728892
[TBL] [Abstract][Full Text] [Related]
2. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
3. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase.
Sangawa H; Komeno T; Nishikawa H; Yoshida A; Takahashi K; Nomura N; Furuta Y
Antimicrob Agents Chemother; 2013 Nov; 57(11):5202-8. PubMed ID: 23917318
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of 3'-azido-3'-azido-3'-deoxy- ribavirin-5'-triphosphate on RNA synthesis catalyzed by RNA polymerase from influenza A virus and by cellular DNA-dependent RNA polymerase II].
Pravdina NF; Galegov GA
Vopr Med Khim; 1989; 35(1):104-6. PubMed ID: 2472705
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase.
Vo NV; Young KC; Lai MM
Biochemistry; 2003 Sep; 42(35):10462-71. PubMed ID: 12950173
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
Meneghesso S; Vanderlinden E; Stevaert A; McGuigan C; Balzarini J; Naesens L
Antiviral Res; 2012 Apr; 94(1):35-43. PubMed ID: 22306172
[TBL] [Abstract][Full Text] [Related]
8. Antiviral effect of octyl gallate against influenza and other RNA viruses.
Yamasaki H; Uozaki M; Katsuyama Y; Utsunomiya H; Arakawa T; Higuchi M; Higuti T; Koyama AH
Int J Mol Med; 2007 Apr; 19(4):685-8. PubMed ID: 17334645
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin: recent insights into antiviral mechanisms of action.
Reyes GR
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):651-6. PubMed ID: 12825459
[TBL] [Abstract][Full Text] [Related]
10. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
11. Favipiravir (T-705), a novel viral RNA polymerase inhibitor.
Furuta Y; Gowen BB; Takahashi K; Shiraki K; Smee DF; Barnard DL
Antiviral Res; 2013 Nov; 100(2):446-54. PubMed ID: 24084488
[TBL] [Abstract][Full Text] [Related]
12. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
Leyssen P; De Clercq E; Neyts J
Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
[TBL] [Abstract][Full Text] [Related]
13. Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir).
Naesens L; Guddat LW; Keough DT; van Kuilenburg AB; Meijer J; Vande Voorde J; Balzarini J
Mol Pharmacol; 2013 Oct; 84(4):615-29. PubMed ID: 23907213
[TBL] [Abstract][Full Text] [Related]
14. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.
Furuta Y; Komeno T; Nakamura T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):449-463. PubMed ID: 28769016
[TBL] [Abstract][Full Text] [Related]
15. Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.
Jin Z; Tucker K; Lin X; Kao CC; Shaw K; Tan H; Symons J; Behera I; Rajwanshi VK; Dyatkina N; Wang G; Beigelman L; Deval J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7504-16. PubMed ID: 26392512
[TBL] [Abstract][Full Text] [Related]
16. Physiological analysis of the stringent response elicited in an extreme thermophilic bacterium, Thermus thermophilus.
Kasai K; Nishizawa T; Takahashi K; Hosaka T; Aoki H; Ochi K
J Bacteriol; 2006 Oct; 188(20):7111-22. PubMed ID: 17015650
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and antiviral activity of ribavirin.
Parker WB
Virus Res; 2005 Feb; 107(2):165-71. PubMed ID: 15649562
[TBL] [Abstract][Full Text] [Related]
18. The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase.
Jin Z; Smith LK; Rajwanshi VK; Kim B; Deval J
PLoS One; 2013; 8(7):e68347. PubMed ID: 23874596
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
[TBL] [Abstract][Full Text] [Related]
20. [Favipiravir, a new concept of antiviral drug against influenza viruses].
Reina J; Reina N
Rev Esp Quimioter; 2017 Apr; 30(2):79-83. PubMed ID: 28176519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
